Discover the groundbreaking Nativus®
process, where placenta processing reaches new heights.
Minimal manipulation
Native state
Never frozen
No micronization
No harsh chemicals
No lyophilization
Minimal degradation of tissue structure
Minimal denaturation of proteins
Strict adherence to FDA CFR Title 21, Part 1271, Section 361 HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Products) regulations Patent application submitted May 9th, 2018
